In a ribbon-cutting ceremony Sartorius inaugurated its new plant at the Sartorius Group’s location in Bangalore, India. Together with some 100 guests from the scientific community and politics, CEO Dr Joachim Kreuzburg,
Supervisory Board Chairman Professor Arnold Picot and MD of Sartorius India Amit Chatterjee officially started up operations at the large building complex covering 10,000 square meters. At its new site, Sartorius has combined its five decentralised individual locations in Bangalore into a single new plant on premises comprising an area of 40,000 square meters or 430,560 square feet, thus creating new capacity for the company’s fast-growing Indian business in both Group divisions. Among other products, Sartorius in Bangalore, India, develops and manufactures bioreactors and additional equipment for pharmaceutical customers, lab equipment as well scales and other weighing equipment for industrial applications. The Sartorius Group invested approximately 5 million euros in the new plant complex.
In his address to the attendees, Dr Kreuzburg stated that for over two decades Sartorius has built up a strong position in India with respect to its local and global customers from the biotech, pharmaceutical and food
sectors. Following its German sites with some 2,220 employees, Sartorius India, with its staff numbering nearly 500 members, now has the second-largest workforce within the entire Sartorius Group. “I am especially delighted that despite the impact of the financial and economic crisis, we can propel the further development of our business in India forward with our new plant,“ said Dr Kreuzburg. Dr Kreuzburg continued, “Many of our international key accounts are increasingly expanding their production and research facilities in India and are manufacturing products there in compliance with international standards.